APA (7th ed.) Citation

PA, Z., N, P., JCM, J., N, v. G., M, D., PJF, d. J., . . . MCW, S. (2026). Aberrant p53 expression, a stronger risk factor for neoplastic progression in Barrett's esophagus than confirmed low grade dysplasia: A large multicenter prospective cohort study. Endoscopy. https://doi.org/10.1055/a-2863-0566

Chicago Style (17th ed.) Citation

PA, Zellenrath, Provoost N, Jansen JCM, van Gerwen N, Doukas M, de Jonge PJF, Koch AD, Honing J, and Spaander MCW. "Aberrant P53 Expression, a Stronger Risk Factor for Neoplastic Progression in Barrett's Esophagus than Confirmed Low Grade Dysplasia: A Large Multicenter Prospective Cohort Study." Endoscopy 2026. https://doi.org/10.1055/a-2863-0566.

MLA (9th ed.) Citation

PA, Zellenrath, et al. "Aberrant P53 Expression, a Stronger Risk Factor for Neoplastic Progression in Barrett's Esophagus than Confirmed Low Grade Dysplasia: A Large Multicenter Prospective Cohort Study." Endoscopy, 2026, https://doi.org/10.1055/a-2863-0566.